comparemela.com

Latest Breaking News On - Laxai life sciences private ltd - Page 1 : comparemela.com

CSIR Start Trials on Niclosamide for Treating COVID-19

New multi-centric, phase-II, randomized, open-label clinical trial evaluates efficacy, safety and tolerability of NIclosamide for the treatment of hospitalized COVID-19 patients.

Laxai life sciences private ltdMinistry of science technologyCouncil for scientificIndustrial researchLife sciences private ltdCovid 19Phase 2 trialsCouncil for scientific and industrial researchNti helminiticலக்சை வாழ்க்கை அறிவியல் ப்ரைவேட் லிமிடெட்அமைச்சகம் ஆஃப் அறிவியல் தொழில்நுட்பம்சபை க்கு அறிவியல்தொழில்துறை ஆராய்ச்சி

CSIR, Laxai start phase-II trials for Niclosamide to treat Covid

Niclosamide is used to treat tapeworm’s infection in adults and children.

Jammu and kashmirCity ofUnited kingdomRam upadhayayaShekharc mandeLaxai life sciences private ltdKing collegeMinistry of science technologyCouncil for scientificIndustrial researchDirector generalLaxai life sciencesPhase ii trialsCovid 19ஜம்மு மற்றும் காஷ்மீர்நகரம் ஆஃப்

vimarsana © 2020. All Rights Reserved.